Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature

Pediatric Endocrinology Reviews

Volumn 7, Issue 4, 2010, Pages 339-346

  Domené, Horacio M ^a   Scaglia, Paula A ^a   Jasper, Héctor G ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Acid labile subunit; Growth hormone insensitivity; IGFALS gene mutations; Insulin like growth factor binding protein; Insulin like growth factor I

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TERNARY COMPLEX FACTOR; CARRIER PROTEIN; GLYCOPROTEIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT;

ACID LABILE SUBUNIT DEFICIENCY; ARTICLE; BODY HEIGHT; GENE MUTATION; GROWTH RETARDATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN SENSITIVITY; POSTNATAL GROWTH; PRENATAL GROWTH; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; SHORT STATURE; ANIMAL; BODY WEIGHT; BONE; CHILD; GENETICS; GROWTH DISORDER; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE;

ANIMALS; BODY HEIGHT; BODY WEIGHT; BONE AND BONES; CARRIER PROTEINS; CHILD; GLYCOPROTEINS; GROWTH DISORDERS; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE;

EID: 77956091888     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-1026 (Pubitemid 129500530)
2. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986;5:2503-2512
3. Baxter RC, Dai J. Purification and characterization of the acidlabile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 1994;134:848-852 (Pubitemid 32677522)
4. Furlanetto RM. The somatomedin C binding protein: evidence for an heterologous subunit structure. J Clin Endocrinol Metab 1980;51:12-19
5. Janosi JB, Ramsland PA, Mott MR, Firth SM, Baxter RC, Delhanty PJ. The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy. J Biol Chem 1999;274:23328-23332 (Pubitemid 34787363)
6. Baxter RC. Circulating levels and molecular distribution of the acid-labile a-subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 1990;70:1347-1353 (Pubitemid 40684626)
7. Guler H-P, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol 1989;121:753-758 (Pubitemid 40434064)
8. Boisclair YR, Rhoads RP, Ueki I, Wang J, Ooi GT. The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 2001;170:63-70 (Pubitemid 43880631)
9. Ueki I, Ooi GT, Tremblay ML, Hurst KR, Bach LA, Boisclair YR. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Nat Acad Sci 2000; 97:6868-6873 (Pubitemid 26230530)
10. Domené HM, Bengolea SV, Martinez AS, Ropelato MG, Pennisi P, Scaglia P, Heinrich JJ, Jasper HG. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. New Engl J 2004:350:570-577 (Pubitemid 28385203)
11. Hwa V, Haeusler G, Pratt K, Little B, Frisch H, Koller D, Rosenfeld R. Total absence of functional acid labile subunit, resulting in severe insulin-like Growth factor deficiency and moderate growth failure. J Clin Endocrinol Metab 2006;91:1826-1831
12. Domené HM, Scaglia PA, Lteif A, Mahmud FH, Kirmani S, Frystyk J, Bedecarrás P, Gutiérrez M, Jasper HG. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations. J Clin Endocrinol Metab 2007;92:4444-4450 (Pubitemid 43880630)
13. Heath KE, Argente J, Barrios V, Pozo J, Díaz-González F, MartosMoreno GA, Caimari M, Gracia R, Campos-Barros Á. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia.-J Clin Endocrinol Metab 2008;93:1616-1624
14. Van Duyvenvoorde HA, Kempers MJ, Twickler TB, van Doorn J, Gerver WJ, Noordam C, Losekoot M, Karperien M, Wit JM, Hermus AR. Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit. Eur J Endocrinol 2008;159:113-120
15. Fofanova-Gambetti OV, Hwa V, Kirsch S, Pihoker C, Chiu HK, Högler W, Cohen LE, Jacobsen C, Derr MA, Rosenfeld RG. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/ IGFBP-3 deficiency in children of different ethnic origins. Horm Res 2009;71:100-110
16. Domené HM, Hwa V, Argente J, Wit JM, Camacho-Hübner C, Jasper HG, Pozo J, van Duyvenvoorde HA, Yakar S, Fofanova-Gambetti OV, Rosenfeld RG; International ALS Collaborative Group. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Horm Res 2009;72:129-141
17. David A, Rose S, Miraki-Moud F, Metherell L, Klark A, Savage M, Camacho-Hubner C. Acid-labile subunit gene mutations: clinical, biochemical and molecular study in two unrelated families. Horm Res 2008;70 (Suppl 1):31. Abstract, 71st Annual Meeting of the European Society for Pediatric Endocrinology, Istanbul, Turkey, September 30-23, 2008
18. Bang P, Fureman A-L, Nilsson A-L, Boström J, Kriström B, Ekström K, Hwa V, Rosenfeld R, Carlsson-Skwirut C. A novel missense mutation of the ALSIGF gene causing a L172F substitution in LRR6 is associated with short stature in two Swedish children homozygous or compound heterozygous for the mutation. Horm Res 2009;72 (Suppl 3):86. Abstract, 8th Joint LWPES/ESPE Meeting, New York, September 9-12, 2009
19. Gallego-Gomez E, Sanchez del Pozo J, Rojo JC, Zurita-Munoz O, Gracia-Bouthelier R, Health KE, Campos-Barros A. Novel compound IGFALS mutation associated with impaired postnatal growth and low circulating IGF-I and IGFBP-3 levels. Horm Res 2009;72 (Suppl 3):90. Abstract, 8th Joint LWPES/ESPE Meeting, New York, September 9-12, 2009
20. Savage MO, Attie KM, David A, Metherell LA, Clark AJL, CamachoHubner C. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nat Clin Pract Endocrinol Metab 2006;2:395-407
21. Daughaday WH, Domené HM, Martinez A, Jasper HG. N Engl J Med 2004;350:1906 (Correspondence)
22. Domené HM, Martinez AS, Frystyk J, Bengolea SV, Ropelato MG, Scaglia PA, Chen J-W, Heuck C, Wolthers OD, Heinrich JJ, Jasper HG. Normal growth spurt and final height despite low levels of all forms of circulating Insulin-like growth-factor-I in a patient with acid-labile subunit deficiency. Horm Res 2007;67:243-249
23. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001;50:1110-1118
24. Ueki I, Ooi GT, Tremblay ML, Hurst KR, Bach LA, Boisclair YR. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci USA 2000;97:6868-6873
25. Sato M, Frohman LA. Differential effect of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamus GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 1993;133:793-799
26. Ohlsson C, Mohan S, Sjögren K, Tivesten Á, Isgaard J, Isackson O, Jansson J-O, Svensson J. The role of liver-derived insulin-like growth factor-I. Endocr Rev 2009;30:494-535
27. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 2001;86:5813-5818
28. Dominici FP, Argentino DP, Muñoz MC, Miquet JG, Sotelo Al, Turyn D. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Hormone and IGF Research 2005;15:324-336
29. Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 2004;113:25-27
30. Yakar S, Rosen CJ, Beamer, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D. Circulating levels of IGF-I directly regulate bone growth and density. J Clin Invest 2002;110:771-781
31. Domené HM, Bengolea SV, Jasper HG, Boisclair YR. Acid-labile subunit deficiency: Phenotypic similarities and differences between human and mouse. J Endocrinol Invest 2005;28:43-46
32. Fofanova-Gambetti OV, Hwa V, Wit JM, Domené HM, Argente J, Bang P, Hogler W, Kirsch S, Pihoker C, Chiu HK, Cohen L, Jacobsen C, Jasper HG, Rosenfeld RG. Auxological implications of heterozygous IGFALS mutations. Horm Res 2009;72(Suppl 3):89. Abstract, 8th Joint LWPES/ ESPE Meeting, New York, September 9-12, 2009
33. David A, Rose S, Miraki-Moud F, Metherell L, Jones J, Edwards R, Camacho-Hubner C, Johnston L, Savage M, Klark A. Heterozygous defect of the acide-labile subunit gene in idiopathic short stature. Horm Res 2008;70(Suppl 1):31. Abstract, 71st Annual Meeting of the European Society for Pediatric Endocrinology, Istanbul, Turkey, September 30-23, 2008
34. Scaglia PA, Domene HM, Martinez AS, Keselman AC, Pipman VR, Bengolea SV, Karabatas LM, Lescano EM, Ropelato MG, Ballerini MG, Heinrich JJ, Jasper HG. Heterozygous IGFALS gene mutations are present in both idiopathic short stature (ISS) and in normal children: impact on height and acid-labile subunit (ALS) levels. Horm Res 2009; 72(Suppl 3):246. Abstract, 8th Joint LWPES/ESPE Meeting, New York, September 9-12, 2009
35. Wu S, Walenkamp MJ, Lankester A, Bidlinmaier M, Wit JM, De Luca F. Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an IkBa mutation. J Clin Endocrinol Metab 2010